| 标题 |
Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment study using biomarker‐guided patient selection |
| 网址 | |
| DOI | |
| 其它 |
期刊:Diabetes, Obesity and Metabolism 作者:Xiaoxue Zhu; Dalong Zhu; M Kellis; Yalin Li; Xiaowei Jin; et al 出版日期:2018-04-30 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)